313 results on '"Hennenlotter, Joerg"'
Search Results
2. Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS
3. Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria
4. Transurethral Resection of Bladder Tumors: Next-generation Virtual Reality Training for Surgeons
5. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin
6. Androgen receptor overexpression in prostate cancer in type 2 diabetes
7. Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity
8. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma
9. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance
10. Prognostic impact of somatostatin receptor expression in advanced bladder cancer
11. Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness
12. γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material
13. Impaired estimated glomerular filtration rate is a significant predictor for non–muscle-invasive bladder cancer recurrence and progression—Introducing a novel prognostic model for bladder cancer recurrence
14. Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer
15. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study
16. Circulating Fibronectin Controls Tumor Growth
17. Transketolase like 1 (TKTL1) expression alterations in prostate cancer tumorigenesis
18. Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder Cancer
19. Thymidine kinase and cancer monitoring
20. Influence of Renal Excretory Function on the Performance of Urine Based Markers to Detect Bladder Cancer
21. Nomograms including the UBC (R) Rapid test to detect primary bladder cancer based on a multicentre dataset
22. Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study
23. HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer
24. Expansion and Differentiation of Neural Progenitors Derived From the Human Adult Enteric Nervous System
25. The Commonly Performed Nerve Sparing Total Prostatectomy Does Not Acknowledge the Actual Nerve Courses
26. Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection
27. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer
28. The Periprostatic Autonomic Nerves—Bundle or Layer?
29. XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma
30. Flow matters: irrigation flow differs in flexible ureteroscopes of the newest generation
31. Effective Treatment of Neurogenic Detrusor Dysfunction by Combined High-Dosed Antimuscarinics without Increased Side-Effects
32. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1
33. Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface
34. Investigations of Urothelial Cells Seeded on Commercially Available Small Intestine Submucosa
35. Diagnostic Value of MRI in a Pelvic Mass of Prostatic Origin
36. MRI-Guided Biopsy of the Prostate Increases Diagnostic Performance in Men with Elevated or Increasing PSA Levels after Previous Negative TRUS Biopsies
37. Laparoscopic Sentinel Lymph Node Dissection – A Novel Technique for the Staging of Prostate Cancer
38. High cytoplasmic expression of p27Kip1 is associated with a worse cancer-specific survival in clear cell renal cell carcinoma
39. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications
40. Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases
41. Quantification of Tumor Cell Burden by Analysis of Single Cell Lymph Node Disaggregates in Metastatic Prostate Cancer
42. Cathepsin D Expression in Renal Cell Cancer–Clinical Implications
43. Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma
44. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance
45. Abstract 5687: Integrative -omics analysis to identify drug targets for ccRCC immunotherapy
46. Abstract 1632: Identification and analysis of EGLN3 as tumor-associated peptide in ccRCC
47. The thermoexpandable nitinol stent: a long-term alternative in patients without nephropathy or malignancy
48. Abstract 1693: Nicotinamide N-methyltransferase in clear cell renal cell carcinoma primary tumors and metastases
49. MP41-03 EXPRESSION OF SOMATOSTATIN RECEPTORS IN PATIENTS WITH ADVANCED BLADDER CANCER IS AN INDICATOR FOR FAVORABLE OUTCOME
50. MP29-03 MTOR EXPRESSION IN PROSTATE CANCER AND IMPLICATIONS AS PROGNOSTIC ROLE WITH META-ANALYSIS OF THE LITERATURE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.